# Reward Mechanisms in Obesity

> **NCT03347890** · PHASE4 · COMPLETED · sponsor: **Zoltan Pataky** · enrollment: 70 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml or Placebo

## Key facts

- **NCT ID:** NCT03347890
- **Lead sponsor:** Zoltan Pataky
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-05
- **Primary completion:** 2020-03-18
- **Final completion:** 2020-03-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2021-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03347890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03347890, "Reward Mechanisms in Obesity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03347890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*